Methylphenidate Facilitates Hypnotizability in Adults With ADHD: A Naturalistic Cohort Study

被引:3
|
作者
Lotan, Amit [1 ]
Bonne, Omer [1 ]
Abramowitz, Eitan G. [1 ]
机构
[1] Hadassah Hebrew Univ, Med Ctr, IL-91120 Jerusalem, Israel
关键词
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; HYPNOTIC-SUSCEPTIBILITY; PREVALENCE; DIAGNOSIS; STABILITY; HYPNOSIS; SYSTEM;
D O I
10.1080/00207144.2015.1031547
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Impaired attention may impede learning of adaptive skills in ADHD. While manipulations that reduce competition between attentional processes, including hypnosis, could boost learning, their feasibility in ADHD is unknown. Because hypnotic phenomena rely on attentional mechanisms, the authors aimed to assess whether stimulants could enhance hypnotizability in ADHD. In the current study, stimulant-naive patients seeking treatment for ADHD-related symptoms were assessed with the Stanford Hypnotic Susceptibility Scale (SHSS) at baseline and during methylphenidate treatment. Methylphenidate dose and SHSS increase were negatively correlated with baseline SHSS scores. Upon reaching effective doses, mean SHSS scores increased significantly. All patients who had been poorly hypnotizable at baseline demonstrated moderate-to-high hypnotizability at follow-up. The data support methylphenidate enhancement of hypnotizability in ADHD, thus highlighting novel treatment approaches for this disabling disorder.
引用
收藏
页码:294 / 308
页数:15
相关论文
共 50 条
  • [1] Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage
    Maria D. Chermá
    Martin Josefsson
    Irene Rydberg
    Per Woxler
    Tomas Trygg
    Olle Hollertz
    Per A. Gustafsson
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 295 - 307
  • [2] Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage
    Cherma, Maria D.
    Josefsson, Martin
    Rydberg, Irene
    Woxler, Per
    Trygg, Tomas
    Hollertz, Olle
    Gustafsson, Per A.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (02) : 295 - 307
  • [3] Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study
    Ventura, Patrizia
    de Giambattista, Concetta
    Trerotoli, Paolo
    Cavone, Maddalena
    Di Gioia, Alessandra
    Margari, Lucia
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [4] Continuity of methylphenidate treatment in adults with ADHD
    Olfson, Mark
    Marcus, Steven C.
    Zhang, Huabin F.
    Wan, George J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 877 - 877
  • [5] The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
    Bies, Rafal
    Fojcik, Joanna
    Warchala, Anna
    Tredzbor, Beata
    Krysta, Krzysztof
    Piekarska-Bugiel, Katarzyna
    Krzystanek, Marek
    PHARMACEUTICALS, 2023, 16 (09)
  • [6] ASSOCIATION BETWEEN ADHD, METHYLPHENIDATE, AND PRECOCIOUS PUBERTY: A NATIONWIDE COHORT STUDY
    Liu, Yi-Chun
    Liao, Yin-To
    Chen, Vincent Chin-Hung
    Chen, Yi-Lung
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28
  • [7] Impact of methylphenidate on sleep problems in adults with ADHD: a pilot polysomnography study
    Fredriksen, Mats
    Golparian, Neshat
    Beiske, Kornelia
    Stavem, Knut
    NORDIC JOURNAL OF PSYCHIATRY, 2021, 75 (03) : 234 - 238
  • [8] A 6 month study of the adherence, effectiveness and safety with methylphenidate adults with ADHD
    Ramos-Quiroga, J. A.
    Bosch, R.
    Castells, X.
    Valero, S.
    Nogueira, M.
    Yelmo, S.
    Garcia, E.
    Martinez, I.
    Casas, M.
    EUROPEAN PSYCHIATRY, 2007, 22 : S63 - S63
  • [9] Methylphenidate modifies reward cue responses in adults with ADHD: An fMRI study
    Furukawa, Emi
    Molina da Costa, Raquel Quimas
    Bado, Patricia
    Hoefle, Sebastian
    Vigne, Paula
    Monteiro, Myriam
    Wickens, Jeff R.
    Moll, Jorge
    Tripp, Gail
    Mattos, Paulo
    NEUROPHARMACOLOGY, 2020, 162
  • [10] Management of methylphenidate in adults with ADHD: Benefits and risks
    Simon, N.
    EUROPEAN PSYCHIATRY, 2015, 30 (08) : S28 - S29